| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Petras Stirbys | |
| P2860 | cites work | Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure | Q24684669 |
| Is the Atrial Neural Plexis a Therapeutic Target in Atrial Fibrillation? | Q26797443 | ||
| Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle | Q44732729 | ||
| Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population | Q48974379 | ||
| Gross and microscopic anatomy of the canine intrinsic cardiac nervous system. | Q50773222 | ||
| Interactive atrial neural network: Determining the connections between ganglionated plexi. | Q51925863 | ||
| Impact of the order of the targeted pulmonary vein on the vagal response during second-generation cryoballoon ablation. | Q53233402 | ||
| 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q56986288 | ||
| PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study | Q58377739 | ||
| Effect of Age and Sex on Left Atrial Morphology and Function | Q61716788 | ||
| Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation | Q61965137 | ||
| Structural correlate of atrial fibrillation in human patients | Q74292163 | ||
| Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation | Q80146849 | ||
| Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction | Q83221425 | ||
| Atrial fibrillation substrate: the "unknown species"-- from lone atrial fibrillation to fibrotic atrial cardiomyopathy | Q83244695 | ||
| Autonomic elements within the ligament of Marshall and inferior left ganglionated plexus mediate functions of the atrial neural network | Q83426906 | ||
| Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects | Q83861411 | ||
| Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors | Q84034335 | ||
| Mechanisms of postoperative atrial tachycardia following biatrial surgical ablation of atrial fibrillation in relation to the surgical lesion sets | Q87000078 | ||
| Ablation of epicardial ganglionated plexi increases atrial vulnerability to arrhythmias in dogs | Q87948744 | ||
| Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate | Q26799163 | ||
| Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation | Q26864767 | ||
| Atrial fibrillation in the elderly: facts and management | Q28194194 | ||
| Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation | Q28269833 | ||
| Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study | Q30491056 | ||
| Lone atrial fibrillation: does it exist? | Q33560948 | ||
| Atrial fibrillation: the most common arrhythmia | Q34091039 | ||
| Structural remodelling during chronic atrial fibrillation: act of programmed cell survival | Q34369718 | ||
| Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase | Q34651371 | ||
| Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats | Q34721297 | ||
| Identification of left atrial ganglionated plexi by dense epicardial mapping as ablation targets for the treatment of concomitant atrial fibrillation | Q34851574 | ||
| Atrial fibrillation: current knowledge and future directions in epidemiology and genomics | Q35526930 | ||
| Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial | Q35926637 | ||
| Aging, metabolic syndrome and the heart. | Q36031750 | ||
| Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. | Q36114005 | ||
| Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences | Q36603719 | ||
| Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system | Q36713691 | ||
| Potential clinical relevance of the 'little brain' on the mammalian heart | Q36992674 | ||
| Heat shock proteins as molecular targets for intervention in atrial fibrillation | Q37104469 | ||
| Histopathological substrate for chronic atrial fibrillation in humans | Q37142669 | ||
| Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes | Q37164851 | ||
| Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. | Q37380393 | ||
| Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future | Q37468899 | ||
| Localization of left atrial ganglionated plexi in patients with atrial fibrillation | Q37534793 | ||
| Neural mechanisms of atrial arrhythmias | Q37938625 | ||
| Dysfunction of the autonomic nervous system in atrial fibrillation | Q38365023 | ||
| Atrial tachyarrhythmias after atrial switch operation for transposition of the great arteries: Treating old surgery with new catheters | Q38790641 | ||
| Prolonged atrial refractoriness predicts the onset of atrial fibrillation: A 12-year follow-up study. | Q38891400 | ||
| Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients | Q39506993 | ||
| Underweight is a risk factor for atrial fibrillation: A nationwide population-based study. | Q39807259 | ||
| Ganglionated plexi and ligament of Marshall ablation reduces atrial vulnerability and causes stellate ganglion remodeling in ambulatory dogs | Q41643070 | ||
| Upstream therapy in patients with early atrial fibrillation: The relevance of the Routine versus Aggressive upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study | Q41684710 | ||
| Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia | Q42407406 | ||
| Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure | Q44025903 | ||
| P433 | issue | 4 | |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 1503 | |
| P577 | publication date | 2016-12-31 | |
| P1433 | published in | Journal of atrial fibrillation | Q27722487 |
| P1476 | title | Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia". | |
| P478 | volume | 9 |
| Q55454785 | Abnormal Atrial Activation at Surface Electrocardiogram Examination in Born Underweight Young Adults. |
| Q55455553 | Aging-Induced Biological Changes and Cardiovascular Diseases. |
| Q55438072 | Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers. |
Search more.